ARCHIVES

GlaxoSmithKline Partners With MD Anderson, Fred Hutchinson

This article is from The Cancer Letter archive.

Vol. 38 No. 46 | December 14, 2012

Download PDF Visit The Full Archive

Related Articles

In Brief: Bruce Chabner, DC director, To Leave NCI Next Spring For Position At Mass General

October 28, 1994

Two Phase II Trials Display Ramucirumab Potential Efficacy

October 26, 2012

Other Concepts Approves By DCE Board Last Week

June 20, 1986

FDA Approves Generic Version Of Capecitabine for Metastatic Colorectal and Breast Cancer

September 27, 2013

Cooperative Groups Advised To Plan For Future Of Less Funding from NCI

June 16, 1995

Also von Eschenbach Role in Industry Program Raises New Concerns of Conflict of Interest.

November 22, 2006